Frost & Sullivan's latest analysis, Growth Opportunities in Global Pharmaceutical Industry, 2026, finds that the pharmaceutical industry is entering a period of profound transformation as ...

An ASSOCHAM report projects India's pharma market to cross USD 120 billion by 2030, driven by global exports, AI drug discovery, biosimilars, and a shift from generics to core biotech innovation.

Licensing deal with genXtraits and Mendel supports development of high-performance traits for challenging growing conditions In a move reflecting growing industry efforts to strengthen crop resilience ...

The Council of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) approved the appointment ...

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

AI‑assisted tools are rapidly transforming biotech innovation, enabling faster discovery and more sophisticated experimentation. At the same time, increased reliance on these tools raises complex and ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech-friendly ...

Stefan Oelrich, member of the Board of Management of Bayer AG and head of its Pharmaceuticals Division. [Photo provided to ...

Mergers and acquisitions (M&A) activity across pharmaceutical and biotech sectors has accelerated significantly in 2026, extending the strong recovery that began in 2025. A recent surge in dealmaking ...

The state government has cleared four initiatives, including a startup accelerator in Mangaluru, an industry-academia ...

SBS University and Uttarakhand Council for Biotechnology have signed an MoU to boost biotechnology education, research, ...